Project Number 5U01AG048986-03 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Optimization and preclinical development of soluble gamma-secretase modulators for AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator WAGNER, STEVEN LEE Principal Investigator First Name WAGNER Principal Investigator Last Name STEVEN LEE Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-12-015: Alzheimer's Disease Drug Development Program (U01) FY Overall Cost $1,497,030 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
